Hazel Aranha

By outsourcing high-end processes that demand advanced analytical and technical skills, biopharm companies are reaping substantial savings.

The biotechnology and pharmaceutical industries have some overriding concerns, namely regulatory and compliance issues, insufficient manufacturing capacity, and the economic challenges of producing niche drugs and therapies.